248 related articles for article (PubMed ID: 9774441)
1. Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1.
Yang J; Liang X; Niu T; Meng W; Zhao Z; Zhou GW
J Biol Chem; 1998 Oct; 273(43):28199-207. PubMed ID: 9774441
[TBL] [Abstract][Full Text] [Related]
2. Relation between the flexibility of the WPD loop and the activity of the catalytic domain of protein tyrosine phosphatase SHP-1.
Yang J; Niu T; Zhang A; Mishra AK; Zhao ZJ; Zhou GW
J Cell Biochem; 2001; 84(1):47-55. PubMed ID: 11746515
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1.
Yang J; Cheng Z; Niu T; Liang X; Zhao ZJ; Zhou GW
J Biol Chem; 2000 Feb; 275(6):4066-71. PubMed ID: 10660565
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase SHP-1 specifically recognizes C-terminal residues of its substrates via helix alpha0.
Yang J; Cheng Z; Niu T; Liang X; Zhao ZJ; Zhou GW
J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):14-20. PubMed ID: 11500950
[TBL] [Abstract][Full Text] [Related]
6. SHP family protein tyrosine phosphatases adopt canonical active-site conformations in the apo and phosphate-bound states.
Alicea-Velazquez NL; Boggon TJ
Protein Pept Lett; 2013 Sep; 20(9):1039-48. PubMed ID: 23514039
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and crystallization of the catalytic domain of protein tyrosine phosphatase SHP-1.
Liang X; Meng W; Niu T; Zhao Z; Zhou GW
J Struct Biol; 1997 Nov; 120(2):201-3. PubMed ID: 9417985
[TBL] [Abstract][Full Text] [Related]
8. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
9. Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sites.
Moise G; Gallup NM; Alexandrova AN; Hengge AC; Johnson SJ
Biochemistry; 2015 Oct; 54(42):6490-500. PubMed ID: 26445170
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human protein-tyrosine phosphatase SHP-1.
Yang J; Liu L; He D; Song X; Liang X; Zhao ZJ; Zhou GW
J Biol Chem; 2003 Feb; 278(8):6516-20. PubMed ID: 12482860
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
Lee CH; Kominos D; Jacques S; Margolis B; Schlessinger J; Shoelson SE; Kuriyan J
Structure; 1994 May; 2(5):423-38. PubMed ID: 7521735
[TBL] [Abstract][Full Text] [Related]
12. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.
Jackson DE; Kupcho KR; Newman PJ
J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the specificity of bacterially expressed cytoplasmic protein-tyrosine phosphatases SHP and SH-PTP2 towards synthetic phosphopeptide substrates.
Dechert U; Affolter M; Harder KW; Matthews J; Owen P; Clark-Lewis I; Thomas ML; Aebersold R; Jirik FR
Eur J Biochem; 1995 Aug; 231(3):673-81. PubMed ID: 7649167
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the tyrosine phosphatase SHP-2.
Hof P; Pluskey S; Dhe-Paganon S; Eck MJ; Shoelson SE
Cell; 1998 Feb; 92(4):441-50. PubMed ID: 9491886
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
Eswaran J; von Kries JP; Marsden B; Longman E; Debreczeni JE; Ugochukwu E; Turnbull A; Lee WH; Knapp S; Barr AJ
Biochem J; 2006 May; 395(3):483-91. PubMed ID: 16441242
[TBL] [Abstract][Full Text] [Related]
16. A YopH PTP1B Chimera Shows the Importance of the WPD-Loop Sequence to the Activity, Structure, and Dynamics of Protein Tyrosine Phosphatases.
Moise G; Morales Y; Beaumont V; Caradonna T; Loria JP; Johnson SJ; Hengge AC
Biochemistry; 2018 Sep; 57(36):5315-5326. PubMed ID: 30110154
[TBL] [Abstract][Full Text] [Related]
17. Kinetic comparison of the catalytic domains of SHP-1 and SHP-2.
Niu T; Liang X; Yang J; Zhao Z; Zhou GW
J Cell Biochem; 1999 Jan; 72(1):145-50. PubMed ID: 10025675
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2.
Ren L; Chen X; Luechapanichkul R; Selner NG; Meyer TM; Wavreille AS; Chan R; Iorio C; Zhou X; Neel BG; Pei D
Biochemistry; 2011 Mar; 50(12):2339-56. PubMed ID: 21291263
[TBL] [Abstract][Full Text] [Related]
20. Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.
Imhof D; Wavreille AS; May A; Zacharias M; Tridandapani S; Pei D
J Biol Chem; 2006 Jul; 281(29):20271-82. PubMed ID: 16702225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
